Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02354092Terminated
Randomised, double-blind trial of lidocaine in pain, sponsored by University of California, San Diego. Primary endpoint: Pain at Time of Osmotic Dilator Placement at 5 months. Started Apr 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02354092.